FDA Approves Lumateperone as Adjunct Therapy for Major Depressive Disorder - Drug Topics

Submitted by Anonymous (not verified) on Thu, 11/06/2025 - 16:09

FDA Approves Lumateperone as Adjunct Therapy for Major Depressive Disorder  Drug Topics